Product Information

SULFASALAZINE DR 500 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2843 per EA under NDC 59762010406. Its NADAC has been published 331 times since Apr 22, 2020.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Sulfasalazine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for SULFASALAZINE DR 500 MG TAB has been published 331 times since Apr 22, 2020, and over the history we have for it it has risen 32.8%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.